These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6456241)

  • 21. An increased incidence of Propionibacterium acnes biofilms in acne vulgaris: a case-control study.
    Jahns AC; Lundskog B; Ganceviciene R; Palmer RH; Golovleva I; Zouboulis CC; McDowell A; Patrick S; Alexeyev OA
    Br J Dermatol; 2012 Jul; 167(1):50-8. PubMed ID: 22356121
    [TBL] [Abstract][Full Text] [Related]  

  • 22. General considerations by a clinical bacteriologist regarding antibiotic therapy in acne.
    Holm SE; Burman LG
    Acta Derm Venereol Suppl (Stockh); 1980; Suppl 89():83-5. PubMed ID: 6451131
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical use of a selective culture medium for wild and antibiotic-resistant Propionibacterium acnes.
    Marino C; Stoughton RB
    J Am Acad Dermatol; 1982 May; 6(5):902-8. PubMed ID: 6212602
    [No Abstract]   [Full Text] [Related]  

  • 24. Transconjugation of erm(X) conferring high-level resistance of clindamycin for Cutibacterium acnes.
    Aoki S; Nakase K; Hayashi N; Noguchi N
    J Med Microbiol; 2019 Jan; 68(1):26-30. PubMed ID: 30431414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolving role of Propionibacterium acnes in acne.
    Leyden JJ
    Semin Cutan Med Surg; 2001 Sep; 20(3):139-43. PubMed ID: 11594668
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenesis and pathogenesis related treatment of acne.
    Gollnick HP; Zouboulis CC; Akamatsu H; Kurokawa I; Schulte A
    J Dermatol; 1991 Sep; 18(9):489-99. PubMed ID: 1838558
    [No Abstract]   [Full Text] [Related]  

  • 27. Sensitivity of Propionibacterium acnes isolated from acne patients: comparative study of antimicrobial agents.
    Nishijima S; Kurokawa I; Kawabata S
    J Int Med Res; 1996; 24(6):473-7. PubMed ID: 8959531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propionibacterium acnes and acne.
    Holland KT; Aldana O; Bojar RA; Cunliffe WJ; Eady EA; Holland DB; Ingham E; McGeown C; Till A; Walters C
    Dermatology; 1998; 196(1):67-8. PubMed ID: 9557229
    [No Abstract]   [Full Text] [Related]  

  • 29. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses.
    Kim J; Ochoa MT; Krutzik SR; Takeuchi O; Uematsu S; Legaspi AJ; Brightbill HD; Holland D; Cunliffe WJ; Akira S; Sieling PA; Godowski PJ; Modlin RL
    J Immunol; 2002 Aug; 169(3):1535-41. PubMed ID: 12133981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MLST typing of antimicrobial-resistant Propionibacterium acnes isolates from patients with moderate to severe acne vulgaris.
    Giannopoulos L; Papaparaskevas J; Refene E; Daikos G; Stavrianeas N; Tsakris A
    Anaerobe; 2015 Feb; 31():50-4. PubMed ID: 25451716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Propionibacterial biofilms cannot explain antibiotic resistance but might contribute to some cases of antibiotic recalcitrant acne.
    Coates T; Eady A; Cove J
    Br J Dermatol; 2003 Feb; 148(2):366-7. PubMed ID: 12588400
    [No Abstract]   [Full Text] [Related]  

  • 32. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
    Eady EA; Cove JH; Holland KT; Cunliffe WJ
    Br J Dermatol; 1989 Jul; 121(1):51-7. PubMed ID: 2527056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriology and acne.
    Parish LC; Witkowski JA
    Int J Dermatol; 1984; 23(1):36-7. PubMed ID: 6233232
    [No Abstract]   [Full Text] [Related]  

  • 34. Cytotaxin production by comedonal bacteria (Propionibacterium acnes, Propionibacterium granulosum and Staphylococcus epidermidis).
    Puhvel SM; Sakamoto M
    J Invest Dermatol; 1980 Jan; 74(1):36-9. PubMed ID: 6444322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of bacteria in acne vulgaris: a new approach.
    Holland KT; Cunliffe WJ; Roberts CD
    Clin Exp Dermatol; 1978 Sep; 3(3):253-7. PubMed ID: 32979
    [No Abstract]   [Full Text] [Related]  

  • 36. Pathogenesis of acne vulgaris: recent advances.
    Bhambri S; Del Rosso JQ; Bhambri A
    J Drugs Dermatol; 2009 Jul; 8(7):615-8. PubMed ID: 19588637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acne vaccines: therapeutic option for the treatment of acne vulgaris?
    Kim J
    J Invest Dermatol; 2008 Oct; 128(10):2353-4. PubMed ID: 18787542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pathogenesis of acne.
    Knor T
    Acta Dermatovenerol Croat; 2005; 13(1):44-9. PubMed ID: 15788147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is acne a bacterial disease?
    Guin JD
    J Indiana State Med Assoc; 1981 Jan; 74(1):28-9. PubMed ID: 6453166
    [No Abstract]   [Full Text] [Related]  

  • 40. Propionibacterium acnes resistance to antibiotics in acne patients.
    Leyden JJ; McGinley KJ; Cavalieri S; Webster GF; Mills OH; Kligman AM
    J Am Acad Dermatol; 1983 Jan; 8(1):41-5. PubMed ID: 6219134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.